Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Radiotherapie met of zonder cisplatine bij lokaal recidief endometriumcarcinoom
jul 2024 | Gynaecologische oncologie, Radiotherapie